LeMaitre Vascular Inc (NASDAQ: LMAT) has reported E.P.S. of $0.50 for its third fiscal quarter (ending September 30) versus $0.34 for the same period a year ago — an increase of 47%. For the latest four quarters through September 30, E.P.S. were $1.84 compared to $1.23 a year ago — an increase of 50%.
Recent Price Action
LeMaitre Vascular Inc (NASDAQ: LMAT) stock closed at $88.39 on 10/31/24 after a slight decline of -0.7%. Moreover, this decline was accompanied by unusually high trading volume at 182% of normal. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 1.6% during the last week.
Current PriceTarget Research Rating
LMAT’s future returns on capital are forecasted to be above the cost of capital. Accordingly, the company is expected to continue to be a Value Builder.
LeMaitre Vascular has a current Value Trend Rating of C (Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. LeMaitre Vascular has a poor Appreciation Score of 15 but a good Power Rating of 85, and the Neutral Value Trend Rating results.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment